Henrik Byron Guldhammer

Henrik Byron Guldhammer is a highly experienced professional in the pharmaceutical and biotechnology sectors, currently serving as Senior Manager of Chemical Synthesis at LEO Pharma since January 2017. In this role, Guldhammer oversees the production department responsible for Active Pharmaceutical Ingredients (API) for psoriasis treatment and calcium metabolism disorders, ensuring compliance with GMP and EHS standards while managing the department's budget and production plans. Prior to LEO Pharma, Guldhammer held various managerial positions at Novo Nordisk from September 2005 to December 2016, focusing on maintenance management, project management, and supply chain strategies for biopharmaceutical production. Guldhammer's career began with roles in project coordination and quality assurance, complemented by a strong academic background including a Master’s in Innovation & Business Development and an MBA in International Business.